logo
    Recent advances and industrial viewpoint for biological treatment of wastewaters by oleaginous microorganisms
    47
    Citation
    99
    Reference
    10
    Related Paper
    Citation Trend
    The engineering methodologies and key technologies for the bioreactor design and the scale-up were discussed.The development trends in bioreactors for the production of biotechnology products were described,including a bioreactor system focusing on metabolic flux detection and analysis,the improved stirred-tank bioreactor based on computational fluid dynamics,microbioreactor,bioreactor for mammalian cell,and enzymatic bioreactor.
    Metabolic Engineering
    Scale-up
    Citations (2)
    Cell types used to produce therapeutic products are mainly bacterial and mammalian cells. The goal of this design is to maintain controlled environments inside a bioreactor and use it for biopharmaceutical production in bacteria. An ideal bioreactor must contain means of measuring and controlling different parameters that affect the life of bacteria. Available designs for bioreactors are reviewed in order to provide all possible aspects that can be improved in the proposed design. The aim is to design, assemble and build a bioreactor with the optimal parameters via a human-to-machine communication that can support optimal bacterial growth. The bacteria that is proposed to be studied and grown inside of the bioreactor is Escherichia coli, as it is an extremely important model organism in many fields of research which serve as a fundamental tool in medicine.
    Biopharmaceutical
    Synthetic Biology
    The increased demand for plant secondary metabolites by the pharmaceutical, food, flavor, beverage, and cosmetic industries has necessitated the rapid and mass production of these metabolites using in vitro plant culture systems. Bioreactors provided a suitable alternative to conventional plant culture by facilitating large-scale propagation of plants and production of secondary metabolites. Bioreactors proved to be effective plant culture systems which are genetically stable, low cost, easy to operate, and fully automated. Bioreactors play a very important role in medicinal plant industry and have evolved over time. At present, a variety of bioreactor configurations are available each customized for specific plant cell/tissue so that a stable optimum yield of bioactives is obtained. The chapter discusses briefly about the use of bioreactors in scaling up the production of secondary metabolites, different categories and designs of bioreactors available, factors on which bioreactor function depends, and the different crops in which bioreactor scaling up is attempted.
    Scale-up
    Abstract Application of bioreactors is dominated by industrial production with the consequence that bioreactors also for scientific purposes are mainly used following an empiric pragmatic approach. For the sake of a breakthrough in biotechnology in general, and especially for advanced process development, a more systematic approach is emphasized here. This methodology in bioreactor performance studies is explained and the meaning clarified in a case study of a new type of tubular bioreactor. The central role of so‐called “model bioreactors” in bench‐scale applications is illustrated as a powerful contribution to the optimal design of bioreactors in technical scale. Pilot plant data in case of a tubular reactor for the production of ethanol with Zymomonas and biopesticides with Bacillus thuringiensis are presented.
    Zymomonas mobilis
    Process development
    Scale-up
    Citations (26)
    Stirred tank bioreactors are still the predominant cultivation systems in large scale biopharmaceutical production. Today, several manufacturers provide both reusable and single-use systems, whereas the broad variety of designs and properties lead to deviations in biological performance. Although the methods for bioreactor characterization are well established, varying experimental conditions and procedures can result in significantly different outcomes. In order to guarantee a reliable comparison and evaluation of different single-use and reusable bioreactor types, standardized methods for their characterization are needed. Equally important is the biological capability of bioreactors, which must be accessed by standardized cultivation procedures of industrially relevant organisms (bacteria, yeasts as well as mammalian and animal cell cultures). In addition, the implementation of well-defined uniform procedures for biological and engineering characterization during the development phase can support a fast assessment of the suitability of a bioreactor system. Based on stirred bioreactors, we describe the aspects of the engineering characterization in order to discuss further the biological characterization as a valuable complement. Finally, a case study is presented.
    Biopharmaceutical
    Characterization
    Citations (12)